Attia MW, Klein JD, Zaoutis T: Does a Day Make a Difference? Duration of Illness and Clinical Presentation of Group A beta-hemolytic streptococcal pharyngitis in children. [Infectious Diseases in Clinical Practice] 11(7): 381-384, Jun 1905
Zaoutis T, Moore LS, Furness K, Klein JD: In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates. [Antimicrob Agents Chemother] 45: 1952-54, Jun 1905
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E: Risk factors for increasing multi-drug resistance among extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. [Clin Infect Dis] 40: 1317-24, May 2005
Zaoutis TE, Goyal M, Chu J, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E: Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. [Pediatrics] 115(4): 942-9, Apr 2005
Σελίδα
70
| 74